Skip to main content

Table 3 In-hospital death and weaning from VA-ECMO among patients in the cardiogenic shock group

From: In-hospital mortality and successful weaning from venoarterial extracorporeal membrane oxygenation: analysis of 5,263 patients using a national inpatient database in Japan

 

All

Total in-hospital death

In-hospital death under VA-ECMO

Transferred to other hospitals with VA-ECMO

Weaning from VA-ECMO

Discharged after weaning from VA-ECMO

In-hospital death after weaning from VA-ECMO

Ischemic heart disease, n (%)

1968

1556

(79.1)

725

(36.8)

12

(0.6)

400

(20.3)

831

(42.2)

Heart failure, n (%)*

1621

1099

(67.8)

488

(30.1)

18

(1.1)

504

(31.1)

611

(37.7)

Valvular disease, n (%)

640

493

(77.0)

246

(38.4)

5

(0.8)

142

(22.2)

247

(38.6)

Myocarditis, n (%)*

186

106

(57.0)

24

(12.9)

2

(1.1)

78

(41.9)

82

(44.1)

Cardiomyopathy, n (%)

193

141

(73.1)

57

(29.5)

6

(3.1)

46

(23.8)

84

(43.5)

Takotsubo cardiomyopathy, n (%)

34

22

(64.7)

8

(23.5)

0

(0.0)

12

(35.3)

14

(41.2)

Infectious endocarditis, n (%)

16

12

(75.0)

6

(37.5)

1

(6.3)

3

(18.8)

6

(37.5)

  1. *p < 0.001 for in-hospital death after weaning from venoarterial extracorporeal membrane oxygenation (VA-ECMO) vs. ischemic heart disease